Gilead Sciences GILD
NASDAQ GILD
$147.50 -1.55 (-1.04%)
As of: Oct 1, 2026 · 3:59 PM EDT

Gilead Sciences (GILD) Short-Term Debt repayments (2009 - 2012)

Updated

Gilead Sciences (GILD) recorded Short-Term Debt repayments of -$650 million in Q3 2012.

Analysis

Gilead Sciences (GILD) Short-Term Debt repayments (2009 - 2012) Analysis & Trends

On a TTM basis, Gilead Sciences' Short-Term Debt repayments came in at $50 million as of Sep 30, 2012; for FY2010, it came in at $500 million, up 25.0% from FY2009.

  • Across earlier years, Short-Term Debt repayments came in at $400 million in FY2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Repayment (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 6.45 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Bristol Myers Squibb 127.55 Bn 78.82 Bn 9.25 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2012 -650.00 Mn
Jun 30, 2012 350.00 Mn
Mar 31, 2012 350.00 Mn
Dec 31, 2009 200.00 Mn
API Access

Gilead Sciences Short-Term Debt repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-repayments&ticker=GILD&period=max&api_key=YOUR_API_KEY